There are 2949 resources available
Invited Discussant LBA8_PR and LBA9_PR
Presenter: Andres Cervantes
Session: Presidential Symposium III
Resources:
Slides
Webcast
Q&A and live discussion
Presenter: Andres Cervantes
Session: Presidential Symposium III
Resources:
Webcast
LBA6_PR - Nivolumab (nivo) plus chemotherapy (chemo) versus chemo as first-line (1L) treatment for advanced gastric cancer/gastroesophageal junction cancer (GC/GEJC)/esophageal adenocarcinoma (EAC): First results of the CheckMate 649 study
Presenter: Markus Moehler
Session: Presidential Symposium III
Resources:
Abstract
Slides
Webcast
LBA7_PR - Nivolumab plus chemotherapy versus chemotherapy alone in patients with previously untreated advanced or recurrent gastric/gastroesophageal junction (G/GEJ) cancer: ATTRACTION-4 (ONO-4538-37) study
Presenter: Narikazu Boku
Session: Presidential Symposium III
Resources:
Abstract
Slides
Webcast
LBA8_PR - Pembrolizumab plus chemotherapy versus chemotherapy as first-line therapy in patients with advanced esophageal cancer: The phase 3 KEYNOTE-590 study
Presenter: Ken Kato
Session: Presidential Symposium III
Resources:
Abstract
Slides
Webcast
LBA9_PR - Adjuvant nivolumab in resected esophageal or gastroesophageal junction cancer (EC/GEJC) following neoadjuvant chemoradiation therapy (CRT): First results of the CheckMate 577 study
Presenter: Ronan Kelly
Session: Presidential Symposium III
Resources:
Abstract
Slides
Webcast
Exploring the emerging research with immuno-oncology in CSCC
Presenter: Dirk Schadendorf
Session: Sanofi Genzyme - Immune checkpoint blockade in non-melanoma skin cancer
Resources:
Webcast
Broadening horizons: new data and combinations with PARP inhibitors
Presenter: Isabelle Ray-Coquard
Session: AstraZeneca - Redefining long-term outcomes in the era of personalised medicine: Maintenance treatment in newly diagnosed ovarian cancer
Resources:
Webcast
Live Q&A - 28 September 2020 - 17:00-17:30
Presenter: Pasi Jänne
Session: Daiichi Sankyo -Antibody Drug Conjugates (ADCs): Advancements in the treatment of solid tumours
Resources:
Webcast
Live Q&A - 24 September 2020 - 17:00-17:30
Presenter: Javier Cortés
Session: Medscape - The HER-pathway in advanced solid tumours: Advances in targeting HER2 and future prospects for HER3
Resources:
Webcast